News & Perspective

Aug 08, 2011

Aug 08, 2011

Study puts global 2009 H1N1 infection rate at 11% to 21%

(CIDRAP News) – Researchers who combed through scores of serologic studies estimate that the global cumulative incidence of pandemic H1N1 influenza infection before vaccines became available was probably below 20%, far lower than the 50% that pandemic planners had envisioned as a possible worst case.

Jul 13, 2010

Jul 13, 2010

ICEID COVERAGE Experts anticipate new flu-fighting tools

As the world recovers its bearings after spikes in pandemic flu activity and anticipates how the upcoming flu season will unfold, antiviral and vaccine experts in Atlanta today plotted out the new prevention and treatment tools public health officials may someday use to fine-tune their disease responses.

May 21, 2010

May 21, 2010

WHO: Pandemic showed limits of vaccine production capacity

(CIDRAP News) – Global production of the H1N1 influenza vaccine has made clear that the world still has a long way to go to meet pandemic production capacity goals set by the World Health Organization (WHO) 4 years ago, WHO experts said in a report released this week.

Nov 13, 2009

Nov 13, 2009

WHO notes H1N1 up in some regions, leveling in others

(CIDRAP News) –Pandemic activity is showing early signs of peaking in some parts of North America, but is on the rise in several European countries as well as those in Central and Eastern Asia, the World Health Organization (WHO) reported today.

Sep 18, 2009

Sep 18, 2009

CDC says 3.4 million doses of H1N1 vaccine to ship in early October

(CIDRAP News) – The first wave of H1N1 vaccine will probably consist of 3.4 million doses of MedImmune's nasal-spray product and is likely to reach providers the first week in October, federal health officials said today.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»